TABLE 3.
Outcome variables excluding TBI with abbreviated injury scale of 3 or more points.
| Using of antiplatelet drugs | Using of anticoagulant | |||||
| Outcome | N | Overall, N = 519 | No, N = 483a | Yes, N = 36a | No, N = 504a | Yes, N = 15a |
| Mortality within 24 h | 518 | |||||
| Died | 13 (2.5%) | 13 (2.7%) | 0 (0.0%) | 13 (2.6%) | 0 (0.0%) | |
| Survived | 505 (97.5%) | 469 (97.3%) | 36 (100.0%) | 490 (97.4%) | 15 (100.0%) | |
| 28 day-mortality | 508 | |||||
| Died | 21 (4.1%) | 19 (4.0%) | 2 (5.6%) | 21 (4.3%) | 0 (0.0%) | |
| Survived | 487 (95.9%) | 453 (96.0%) | 34 (94.4%) | 472 (95.7%) | 15 (100.0%) | |
| Mortality at hospital discharge | 517 | |||||
| Died | 25 (4.8%) | 23 (4.8%) | 2 (5.6%) | 25 (5.0%) | 0 (0.0%) | |
| Survived | 492 (95.2%) | 458 (95.2%) | 34 (94.4%) | 477 (95.0%) | 15 (100.0%) | |
| Surgery for hemostasis | 517 | 82 (15.9%) | 79 (16.4%) | 3 (8.3%) | 80 (15.9%) | 2 (13.3%) |
| TAE | 518 | 85 (16.4%) | 79 (16.4%) | 6 (16.7%) | 85 (16.9%) | 0 (0.0%) |
| RBC transfusion | 510 | 0.0 (0.0, 560.0) | 0.0 (0.0, 560.0) | 0.0 (0.0, 420.0) | 0.0 (0.0, 560.0) | 0.0 (0.0, 0.0) |
| FFP transfusion | 510 | 0 (0.0, 480.0) | 0.0 (0.0, 720.0) | 0.0 (0.0, 360.0) | 0.0 (0.0, 600.0) | 0.0 (0.0, 0.0) |
| PC transfusion | 508 | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) |
aStatistical data are presented as the median (interquartile range) or n (%). TAE, transcatheter arterial embolization; RBC, red blood cell; FFP, fresh frozen plasma; PC, platelet concentrate.